66 results match your criteria: "Institute Imagine[Affiliation]"

Article Synopsis
  • - Sickle cell disease (SCD) is caused by mutations in the hemoglobin beta chain gene, leading to the production of abnormal hemoglobin (HbS), which results in symptoms like anemia and painful vaso-occlusive events.
  • - Gene therapy shows promise for treating SCD, with two specific therapies already on the market, but there is a need to enhance their effectiveness, particularly with strategies that involve transferring a corrective beta-globin gene.
  • - Research demonstrates that using cyclosporin H (CsH) during the gene therapy process can improve transgene expression and the number of gene copies in stem cells from cord blood, making it a potential effective combination for treating SCD.
View Article and Find Full Text PDF

Clinical experimental medicine in the UK.

Brain

January 2025

MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh EH4 2XU, UK.

View Article and Find Full Text PDF

The pathogenic expansion of the intronic GGGGCC hexanucleotide located in the non-coding region of the gene represents the most frequent genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This mutation leads to the accumulation of toxic RNA foci and dipeptide repeats (DPRs), as well as reduced levels of the C9orf72 protein. Thus, both gain and loss of function are coexisting pathogenic aspects linked to -ALS/FTD.

View Article and Find Full Text PDF

Detection of seizure onset in childhood absence epilepsy.

Clin Neurophysiol

July 2024

Univ Rennes, INSERM, LTSI - UMR 1099, Rennes F-35000, France.

Objective: This study aims to detect the seizure onset, in childhood absence epilepsy, as early as possible. Indeed, interfering with absence seizures with sensory simulation has been shown to be possible on the condition that the stimulation occurs soon enough after the seizure onset.

Methods: We present four variations (two supervised, two unsupervised) of an algorithm designed to detect the onset of absence seizures from 4 scalp electrodes, and compare their performance with that of a state-of-the-art algorithm.

View Article and Find Full Text PDF

Antiphospholipid syndrome (APS) is a chronic autoimmune disease involving vascular thrombosis and/or obstetric morbidity and persistent antibodies to phospholipids or certain phospholipid-associated proteins. It is a rare condition in adults and even rarer in children. The diagnosis of APS can be facilitated by the use of classification criteria based on a combination of clinical and biological features.

View Article and Find Full Text PDF
Article Synopsis
  • Over two dozen proteins involved in the spliceosome are linked to human diseases, known as spliceosomopathies; WBP4 is a newly identified protein associated with severe neurodevelopmental syndromes.
  • Researchers identified eleven patients from eight families affected by hypotonia, developmental delays, intellectual disabilities, and various organ abnormalities, confirming that mutations in WBP4 are a key factor.
  • Genetic analyses revealed loss-of-function variants leading to a complete loss of WBP4 protein, affecting RNA splicing in genes related to the nervous and musculoskeletal systems, highlighting the need for further studies on the disease mechanisms.
View Article and Find Full Text PDF
Article Synopsis
  • - Transcription of mitochondrial DNA forms long polycistronic precursors, which are then processed into individual transcripts through cleavage by specific enzymes, mainly RNAseP and RNaseZ/ELAC2.
  • - The study describes five patients from three families with varying degrees of cardiomyopathy and neurological issues, highlighting genetic variants associated with these conditions.
  • - Enzymatic and immunoblot analyses revealed deficiencies in energy production pathways and a decrease in ELAC2 protein, supporting its role in processing mitochondrial tRNA precursors, indicating that cardiomyopathy may not always be a defining symptom of the disease.
View Article and Find Full Text PDF

Updating Tuberous sclerosis complex care for pediatric neurologists.

Arch Pediatr

December 2022

Service de neuropédiatrie, Hôpital Necker-Enfants Malades, APHP Paris, Université Paris cité, Paris, France; INSERM U1163, Chaire GEEN-DS, institute Imagine, Paris, France.

View Article and Find Full Text PDF

Dysregulation of the immune response in TGF-β signalopathies.

Front Immunol

December 2022

Université Paris-Cité, Institute Imagine, Laboratory of Intestinal Immunity, INSERM U1163, Paris, France.

The transforming growth factor-β (TGF-β) family of cytokines exerts pleiotropic functions during embryonic development, tissue homeostasis and repair as well as within the immune system. Single gene defects in individual component of this signaling machinery cause defined Mendelian diseases associated with aberrant activation of TGF-β signaling, ultimately leading to impaired development, immune responses or both. Gene defects that affect members of the TGF-β cytokine family result in more restricted phenotypes, while those affecting downstream components of the signaling machinery induce broader defects.

View Article and Find Full Text PDF

Background: HIV-associated cryptococcal meningitis is a leading cause of AIDS-related mortality. The AMBITION-cm trial showed that a regimen based on a single high dose of liposomal amphotericin B deoxycholate (AmBisome group) was non-inferior to the WHO-recommended treatment of seven daily doses of amphotericin B deoxycholate (control group) and was associated with fewer adverse events. We present a five-country cost-effectiveness analysis.

View Article and Find Full Text PDF

Periodic discharges are a rare peculiar electroencephalogram pattern, occasionally associated with motor or other clinical manifestations, usually observed in critically ill patients. Their underlying pathophysiology remains poorly understood. Epileptic spasms in clusters and periodic discharges with motor manifestations share similar electroencephalogram pattern and some aetiologies of unfavourable prognosis such as subacute sclerosing panencephalitis or herpes encephalitis.

View Article and Find Full Text PDF

Introduction: X-linked hypophosphatemia (XLH) is a rare, hereditary, and lifelong phosphate-wasting disorder characterized by rickets in childhood and impaired teeth mineralization. In the oral cavity, spontaneous abscesses can often occur without any clinical signs of alteration of the causal tooth. The objective of our study was to evaluate the oral care pathway and the oral health-related quality of life (OHRQoL) of patients following in an expert oral medicine department located within a Parisian hospital and working in close collaboration with an endocrinology department expert in this pathology.

View Article and Find Full Text PDF

Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsy.

Brain Dev

February 2022

Neurology Department, The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, New South Wales, Australia; Discipline of Child & Adolescent Health, University of Sydney, Sydney, New South Wales 2006, Australia. Electronic address:

Background: The type 1 interferonopathy, Aicardi-Goutières syndrome 6 (AGS6), is classically caused by biallelic ADAR mutations whereas dominant ADAR mutations are associated with dyschromatosis symmetrica hereditaria (DSH). The unique dominant ADAR c.3019G>A variant is associated with neurological manifestations which mimic spastic paraplegia and cerebral palsy (CP).

View Article and Find Full Text PDF

Cerebrospinal fluid neopterin as a biomarker of treatment response to Janus kinase inhibition in Aicardi-Goutières syndrome.

Dev Med Child Neurol

February 2022

Kids Neuroscience Centre, The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Janus kinase (JAK) 1 inhibition represents a precision medicine approach in the treatment of Aicardi-Goutières syndrome (AGS), through targeting of type I interferon-mediated cell signalling. Blood interferon mRNAseq has been proposed as a biomarker of disease with utility in therapeutic monitoring. Objective cerebrospinal fluid (CSF) biomarkers tracking treatment efficacy are currently lacking.

View Article and Find Full Text PDF

Diabetic retinopathy (DR) remains a major cause of vision loss, due to macular edema, retinal ischemia and death of retinal neurons. We previously demonstrated that acute administration of glibenclamide into the vitreous, or given orally at a non-hypoglycemic dose, protected the structure and the function of the retina in three animal models that each mimic aspects of diabetic retinopathy in humans. In this pilot study, we investigated whether one year of chronic oral glibenclamide, in a non-hypoglycemic regimen (Amglidia, 0.

View Article and Find Full Text PDF

Mendelian Susceptibility to Mycobacterial diseases (MSMD) are a group of innate immune defects with more than 17 genes and 32 clinical phenotypes identified. Defects in the IFN-γ mediated immunity lead to an increased susceptibility to intracellular pathogens like mycobacteria including attenuated -Bacillus Calmette-Guérin (BCG) vaccine strains and non-tuberculous environmental mycobacteria (NTM), , fungi, parasites like and some viruses, in otherwise healthy individuals. Mutations in the gene are the commonest genetic defects identified.

View Article and Find Full Text PDF

Objective: Asparagine-linked glycosylation 13 (ALG13) deficiencies have been repeatedly described in the literature with the clinical phenotype of a developmental and epileptic encephalopathy (DEE). Most cases were females carrying the recurrent ALG13 de novo variant, p.(Asn107Ser), with normal transferrin electrophoresis.

View Article and Find Full Text PDF

Pregnancy and Neonatal Outcomes in SARS-CoV-2 Infection: A Systematic Review.

J Pregnancy

October 2020

Genetic Intelligence Laboratory, Weill Cornell Medicine-Qatar, Doha, Qatar.

With the emergence of SARS-CoV-2 and its rapid spread, concerns regarding its effects on pregnancy outcomes have been growing. We reviewed 245 pregnancies complicated by maternal SARS-CoV-2 infection across 48 studies listed on PubMed and MedRxiv. The most common clinical presentations were fever (55.

View Article and Find Full Text PDF

Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.

Gastroenterology

January 2021

The Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Precision Institute of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address:

Background And Aims: The presence of gastrointestinal symptoms and high levels of viral RNA in the stool suggest active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication within enterocytes.

Methods: Here, in multiple, large cohorts of patients with inflammatory bowel disease (IBD), we have studied the intersections between Coronavirus Disease 2019 (COVID-19), intestinal inflammation, and IBD treatment.

Results: A striking expression of ACE2 on the small bowel enterocyte brush border supports intestinal infectivity by SARS-CoV-2.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to improve the management of pediatric Crohn's disease (CD) by identifying prognostic factors associated with adverse outcomes, which could help reduce complications and optimize patient care.
  • After surveying 202 experts and conducting a systematic review, consensus was reached on 27 prognostic factors related to surgery, complications, and disease activity in pediatric CD, highlighting factors like age at diagnosis, disease behavior, and genetic markers.
  • The findings provide valuable insights for treatment strategies, but emphasize the need for further longitudinal studies to better understand the prognostic factors and the effects of different treatments in pediatric CD.
View Article and Find Full Text PDF

Background & Aims: A better understanding of prognostic factors in ulcerative colitis (UC) could improve patient management and reduce complications. We aimed to identify evidence-based predictors for outcomes in pediatric UC, which may be used to optimize treatment algorithms.

Methods: Potential outcomes worthy of prediction in UC were determined by surveying 202 experts in pediatric UC.

View Article and Find Full Text PDF

PRPS1 loss-of-function variants, from isolated hearing loss to severe congenital encephalopathy: New cases and literature review.

Eur J Med Genet

November 2020

Centre de Référence des Surdités Génétiques, Institut Imagine, Hôpital Necker-Enfants Malades, AP-HP.Centre, Paris, France; Fédération de Génétique, Hôpital Necker-Enfants Malades, AP-HP.Centre, Paris, France; Laboratoire d'Embryologie et de Génétique des Malformations Congénitales, INSERM UMR 1163, Institut Imagine, Université Paris Descartes, Paris, France. Electronic address:

We describe two sporadic and two familial cases with loss-of-function variants in PRPS1, which is located on the X chromosome and encodes phosphoribosyl pyrophosphate synthetase 1 (PRS-1). We illustrate the clinical variability associated with decreased PRS-1 activity, ranging from mild isolated hearing loss to severe encephalopathy. One of the variants we identified has already been reported with a phenotype similar to our patient's, whereas the other three were unknown.

View Article and Find Full Text PDF